δ Subunit-containing GABAA receptors are preferred targets for the centrally acting analgesic flupirtine

British Journal of Pharmacology

Volumn 172, Issue 20, 2015, Pages 4946-4958

  Klinger, Felicia ^a   Bajric, Mirnes ^a   Salzer, Isabella ^a   Dorostkar, Mario M ^a   Khan, Deeba ^a   Pollak, Daniela D ^a   Kubista, Helmut ^a   Boehm, Stefan ^a   Koenig, Xaver ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA2; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA3; 4 AMINOBUTYRIC ACID A RECEPTOR BETA3; 4 AMINOBUTYRIC ACID A RECEPTOR GAMMA2; FLUPIRTINE; GABOXADOL; PENICILLIN DERIVATIVE; POTASSIUM CHANNEL KCNQ4; AMINOPYRIDINE DERIVATIVE; ANALGESIC AGENT; POTASSIUM CHANNEL KCNQ;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOBLOTTING; NERVE CELL PLASTICITY; NONHUMAN; PATCH CLAMP TECHNIQUE; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; RAT; SPINAL CORD DORSAL HORN; SPINAL GANGLION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CELL LINE; CYTOLOGY; DRUG EFFECTS; HUMAN; INHIBITORY POSTSYNAPTIC POTENTIAL; METABOLISM; NERVE CELL; PHYSIOLOGY;

AMINOPYRIDINES; ANALGESICS; ANIMALS; CELL LINE; CELLS, CULTURED; GANGLIA, SPINAL; HIPPOCAMPUS; HUMANS; INHIBITORY POSTSYNAPTIC POTENTIALS; KCNQ POTASSIUM CHANNELS; NEURONS; RATS; RECEPTORS, GABA-A; SPINAL CORD DORSAL HORN;

EID: 84942682259     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13262     Document Type: Article

References (40)

1. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013a). The Concise Guide to PHARMACOLOGY 2013/14: ligand-gated ion channels. Br J Pharmacol 170: 1582-1606.
2. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Catterall WA, et al., (2013b). The Concise Guide to PHARMACOLOGY 2013/14: ion channels. Br J Pharmacol 170: 1607-1651.
3. Bai D, Zhu G, Pennefather P, Jackson MF, MacDonald JF, Orser BA, (2001). Distinct functional and pharmacological properties of tonic and quantal inhibitory postsynaptic currents mediated by gamma-aminobutyric acid(A) receptors in hippocampal neurons. Mol Pharmacol 59: 814-824.
4. Boehm S, Betz H, (1997). Somatostatin inhibits excitatory transmission at rat hippocampal synapses via presynaptic receptors. J Neurosci 17: 4066-4075.
5. Bohlhalter S, Weinmann O, Mohler H, Fritschy JM, (1996). Laminar compartmentalization of GABAA-receptor subtypes in the spinal cord: an immunohistochemical study. J Neurosci 16: 283-297.
6. Bonin RP, Labrakakis C, Eng DG, Whissell PD, Koninck Y, De OBA, (2011). Pharmacological enhancement of δ-subunit-containing GABA(A) receptors that generate a tonic inhibitory conductance in spinal neurons attenuates acute nociception in mice. Pain 152: 1317-1326.
7. Brickley SG, Mody I, (2012). Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease. Neuron 73: 23-34.
8. Bright DP, Renzi M, Bartram J, McGee TP, MacKenzie G, Hosie AM, et al., (2011). Profound desensitization by ambient GABA limits activation of δ-containing GABAA receptors during spillover. J Neurosci 31: 753-763.
9. Brown DA, Passmore GM, (2009). Neural KCNQ (Kv7) channels. Br J Pharmacol 156: 1185-1195.
10. Chandra D, Jia F, Liang J, Peng Z, Suryanarayanan A, Werner DF, et al., (2006). GABAA receptor alpha 4 subunits mediate extrasynaptic inhibition in thalamus and dentate gyrus and the action of gaboxadol. Proc Natl Acad Sci U S A 103: 15230-15235.
11. Devulder J, (2010). Flupirtine in pain management: pharmacological properties and clinical use. CNS Drugs 24: 867-881.
12. Dorostkar MM, Boehm S, (2007). Opposite effects of presynaptic 5-HT3 receptor activation on spontaneous and action potential-evoked GABA release at hippocampal synapses. J Neurochem 100: 395-405.
13. Farrant M, Nusser Z, (2005). Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat Rev Neurosci 6: 215-229.
14. Feng H-J, Botzolakis EJ, Macdonald RL, (2009). Context-dependent modulation of alphabetagamma and alphabetadelta GABA A receptors by penicillin: implications for phasic and tonic inhibition. Neuropharmacology 56: 161-173.
15. Friedel HA, Fitton A, (1993). Flupirtine. A review of its pharmacological properties, and therapeutic efficacy in pain states. Drugs 45: 548-569.
16. Hummel T, Friedmann T, Pauli E, Niebch G, Borbe HO, Kobal G, (1991). Dose-related analgesic effects of flupirtine. Br J Clin Pharmacol 32: 69-76.
17. Isaacson JS, Solís JM, Nicoll RA, (1993). Local and diffuse synaptic actions of GABA in the hippocampus. Neuron 10: 165-175.
18. Jakob R, Krieglstein J, (1997). Influence of flupirtine on a G-protein coupled inwardly rectifying potassium current in hippocampal neurones. Br J Pharmacol 122: 1333-1338.
19. Klinger F, Geier P, Dorostkar MM, Chandaka GK, Yousuf A, Salzer I, et al., (2012). Concomitant facilitation of GABAA receptors and KV7 channels by the non-opioid analgesic flupirtine. Br J Pharmacol 166: 1631-1642.
20. Kornhuber J, Bleich S, Wiltfang J, Maler M, Parsons CG, (1999). Flupirtine shows functional NMDA receptor antagonism by enhancing Mg2+ block via activation of voltage independent potassium channels. Rapid Commun J Transm Neural 106: 857-867.
21. Li Y, Gamper N, Hilgemann DW, Shapiro MS, (2005). Regulation of Kv7 (KCNQ) K+ channel open probability by phosphatidylinositol 4,5-bisphosphate. J Neurosci 25: 9825-9835.
22. Ma W, Saunders PA, Somogyi R, Poulter MO, Barker JL, (1993). Ontogeny of GABAA receptor subunit mRNAs in rat spinal cord and dorsal root ganglia. J Comp Neurol 338: 337-359.
23. Maguire JL, Stell BM, Rafizadeh M, Mody I, (2005). Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nat Neurosci 8: 797-804.
24. Mangan PS, Sun C, Carpenter M, Goodkin HP, Sieghart W, Kapur J, (2005). Cultured hippocampal pyramidal neurons express two kinds of GABAA receptors. Mol Pharmacol 67: 775-788.
25. Martire M, Castaldo P, D'Amico M, Preziosi P, Annunziato L, Taglialatela M, (2004). M channels containing KCNQ2 subunits modulate norepinephrine, aspartate, and GABA release from hippocampal nerve terminals. J Neurosci 24: 592-597.
26. Miceli F, Soldovieri M, Martire V, Taglialatela M, (2008). Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs. Curr Opin Pharmacol 8: 65-74.
27. Olsen RW, Sieghart W, (2009). GABA A receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology 56: 141-148.
28. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al., NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucl Acids Res 42 Database Issue: D1098-D1106.
29. Poltl A, Hauer B, Fuchs K, Tretter V, Sieghart W, (2003). Subunit composition and quantitative importance of GABA(A) receptor subtypes in the cerebellum of mouse and rat. J Neurochem 87: 1444-1455.
30. Puia G, Costa E, Vicini S, (1994). Functional diversity of GABA-activated Cl-currents in Purkinje versus granule neurons in rat cerebellar slices. Neuron 12: 117-126.
31. Roepstorff A, Lambert JD, (1994). Factors contributing to the decay of the stimulus-evoked IPSC in rat hippocampal CA1 neurons. J Neurophysiol 72: 2911-2926.
32. Sarto-Jackson I, Milenkovic I, Smalla K-H Gundelfinger ED, Kaehne T, Herrera-Molina R, et al., (2012). The cell adhesion molecule neuroplastin-65 is a novel interaction partner of γ-aminobutyric acid type A receptors. J Biol Chem 287: 14201-14214.
33. Sieghart W, Sperk G, (2002). Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr Top Med Chem 2: 795-816.
34. Sotty F, Damgaard T, Montezinho LP, Mørk A, Olsen CK, Bundgaard C, et al., (2009). Antipsychotic-like effect of retigabine [N-(2-amino-4-(fluorobenzylamino)-phenyl)carbamic acid ester], a KCNQ potassium channel opener, via modulation of mesolimbic dopaminergic neurotransmission. J Pharmacol Exp Ther 328: 951-962.
35. Szelenyi I, (2013). Flupirtine, a re-discovered drug, revisited. Inflamm Res 62: 251-258.
36. Wei W, Zhang N, Peng Z, Houser CR, Mody I, (2003). Perisynaptic localization of delta subunit-containing GABA(A) receptors and their activation by GABA spillover in the mouse dentate gyrus. J Neurosci 23: 10650-10661.
37. Wladyka CL, Kunze DL, (2006). KCNQ/M-currents contribute to the resting membrane potential in rat visceral sensory neurons. J Physiol 575: 175-189.
38. Yeung JYT, Canning KJ, Zhu G, Pennefather P, MacDonald JF, Orser BA, (2003). Tonically activated GABAA receptors in hippocampal neurons are high-affinity, low-conductance sensors for extracellular GABA. Mol Pharmacol 63: 2-8.
39. Yu ZY, Wang W, Fritschy JM, Witte OW, Redecker C, (2006). Changes in neocortical and hippocampal GABAA receptor subunit distribution during brain maturation and aging. Brain Res 1099: 73-81.
40. Zeilhofer HU, Mohler H, Lio AD, (2009). GABAergic analgesia: new insights from mutant mice and subtype-selective agonists. Trends Pharmacol Sci 30: 397-402.